Table 1 General characteristics of included studies
Author, year | Country | Study design | Participants (sample; gender; age) | OMI (sample; dimensions; site; load) | Groups | Evaluation methods | Follow-up time |
|---|---|---|---|---|---|---|---|
Abohabib, 2018 [10] | Egypt | RCT | 15 participants; -; 20.9 ± 3.4 years | 30 OMI; 1.5 mm diameter and 8 mm length; maxilla; IL (150 g) | L group; C group | Stability: RFA using the Osstell ISQ device. Clinical success/failure rates: absence/presence of mobility. | 10 weeks |
Ekizer, 2016 [14] | Turkey | RCT | 20 participants; 13 F/7 M; 16.77 ± 1.41 years | 20 OMI; 1.6 mm diameter and 8 mm length; maxilla; - | L group; C group | Stability: RFA using the Osstell ISQ device. Inflammation: interleukin-1β levels in gingival and peri-implant crevicular fluid | 3 months |
Flieger, 2019 | Poland | RCT | 20 participants; 13 F/7M; 32.5 ± 6.1 years | 40 OMI; 1.4 mm diameter and 10 mm length; maxilla; -. | L group; C group | Stability: PTV using the Periotest device. Pain: NRS-11 | 60 days |
Marañón-Vásquez, 2019 [6] | Brazil | Non-RCT | 19 participants; -; - | 48 OMI for stability; 35 OMI for displacement; 1.5 mm diameter and 8 mm length; maxilla/mandible; IL/DL (150 g) | PBM + IL group; PBM + DL group; IL group/DL group | Stability: RFA using the Osstell ISQ device. Displacement: Images from CBCT | 3 months |
Matys, 2020 [16] | Poland | RCT | 22 participants; 14 F/8 M; 31.7 ± 9.7 years | 44 OMI; 1.4 mm diameter and 10 mm length; maxilla; - | L group; C group | Stability: PTV using the Periotest device. Pain: NRS-11 | 60 days |
Osman, 2017 [15] | Egypt | RCT | 12 participants; 6 F/6 M; 14 to 28 years | 24 OMI; -; maxilla; DL (150 g) | L group; C group | Stability: PTV using the Periotest device. Inflammation: gingival index | 60 days |